Moderna shares pop 7% after Cowen upgrades stock, saying it 'will be a leader' in RSV vaccines

Moderna shares closed nearly 7% after TD Cowen upgraded the stock, saying the company will "be a leader" in the RSV vaccine market.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.